Ikea's first-ever rewards program could help you earn a discount on your next piece of furniture
Ikea just debuted its first-ever rewards program for customers in the U.S., and it could mean a major discount on your next plate of Swedish meatballs—or even a price cut on a new vintage-inspired piece of furniture.
The rewards program launches today, and it allows shoppers to accrue points for a range of actions and then redeem them for various discounts. The rewards are a free add-on to Ikea Family, the store's existing loyalty program (which is also free to join and currently boasts around 24 million members). Any current members of Ikea Family will automatically be enrolled in the rewards program, and new members who sign up will start earning points automatically.
Like most rewards programs, the points system is designed to give shoppers a feel-good boost every time they interact with the Ikea brand. For a company that thrives on cultivating a dedicated fan base through frequent product drops, a store layout designed to cultivate an experience, and plenty of nostalgic callbacks, it's a move that feels like it's been a long time coming.
New system 'reflects how consumers expect to shop'
Currently, members of Ikea Family gain access to a few benefits including reduced delivery fees, discounts on certain products, complimentary in-store beverages, and free in-store workshops. According to Nicole King, customer engagement and loyalty manager at Ikea U.S., the new rewards are meant to 'recognize and add more value' for this core set of Ikea devotees. The U.S. will join Ikea stores in Portugal, Australia, and Italy, which have already introduced the rewards program to shoppers.
'We are working to create a more accessible and convenient retail experience for our customers,' King says. 'Meeting them with a rewards offer that allows them to earn points for interacting with Ikea reflects how consumers expect to shop today.'
How the Ikea rewards points work
There are a variety of ways that members can earn points. To start, every dollar spent online and in person equals 1 point; sharing a gift registry earns 10; and logging into an online account or saving a wish list scores 25. Bigger actions like attending an Ikea event, creating an Ikea Family profile, or making a gift registry garner 50 points.
As these points tally up, they can then be redeemed for a range of perks—though it might take some time, or a lot of aspirational online shopping, to earn anything substantial. At 65 points, members can grab free food at the Ikea Restaurant and Bistro; 175 points allows for a $5 discount on product purchases. And starting at 350 points and more, members can receive $10 off delivery. Beyond 350 points, King says, other potential earnings could include $20 off a product or delivery and $50 off an assembly service.
'Rewards from Ikea Family is based on helping customers bring their ideas to life throughout the journey of dreaming, planning, and implementing their projects,' King explains. 'It's the first step in redefining how we work with loyalty and member engagement in order to enable and sustain a lifetime value for both members and Ikea.'
The new program won't exactly reinvent the wheel, but it might just help draw Ikea's cult following even closer.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
3 hours ago
- Miami Herald
IKEA's new store concept makes its way to this state
I remember the first time I walked into an IKEA store. I was amazed by the vast offering, but a bit annoyed by its layout - how it forces you to walk through the whole store and look at everything. I was annoyed only for one reason - I didn't have time for it, as this was supposed to be just a short stop on the way to somewhere else. Rushing through an IKEA store is no fun, because there are so many nicely designed items that grab your attention, and you want to check them out without time pressure. Don't miss the move: Subscribe to TheStreet's free daily newsletter This just illustrates how remarkable IKEA's marketing strategy really is. A neuromarketer and author of "The Buying Brain," Dr. A.K. Pradeep explains this "Ikea phenomenon" by explaining how its stores appeal to the subconscious mind, which is the primary driver of decision-making, writes CNBC. "Furniture is set up in its natural environment. Every single thing there is contextually in position. The brain perceives it, understands its inherent value, and therefore desires it," Pradeep said. Marketing isn't everything, naturally. IKEA wouldn't be as popular if its offerings were no good. However, the furniture giant is praised for affordable, easy-to-assemble products and Scandinavian aesthetic of simple, minimalist design. Now the Swedish home goods powerhouse is trying to position itself in the U.S. and rival big names such as Ashley HomeStore or Target. Image source: Ratcliffe/Bloomberg via Getty Images Over the past few years, IKEA expanded across multiple states, and it currently has 51 retail locations across the U.S. and 375 IKEA stores in 30 countries. On June 4, the company opened a Plan and Order point store in Beaverton, Oregon, located at Progress Ridge Town Square at 12305 SW Horizon Blvd. Related: Another major furniture chain closes stores, no bankruptcy This new format store is the second IKEA location in the Portland metro area. What is a Plan and Order point store? IKEA's new concept consists of smaller stores dedicated to kitchen, bedroom, and living room planning, where customers can get home furnishing advice to help them design their space. Customers can book an appointment with IKEA's expert planning specialists or use in-store self-service tools to design their own solutions. More Retail: Huge retail chain closing more stores soon (locations revealed)Struggling drugstore chain announces second bankruptcyBeloved discount grocery chain has massive US plans As the name suggests, Plan and Order point stores have no items to buy in-store and take home on the same day, but purchases made there can be home delivered or collected for free from one of the stores or pick-up points. This year, the retail mammoth already opened five locations in the U.S., and it plans six more by the end of the year. What's more, two additional locations are planned for 2026. It all started in 2023, when the company confirmed it would invest $2.2 billion to expand across the U.S. over the next three years by opening new stores and enhancing its fulfillment network. This was the biggest investment in almost 40 years since IKEA's first store opened in Plymouth Meeting, Pennsylvania, writes TheStreet's Fernanda Tronco. Related: Target CEO offers 10,000 items below $5 to win customers back "The U.S. is one of our most important markets, and we see endless opportunities to grow there and get closer to the many Americans with affordable products and services," IKEA Head Retail at Ingka Group, Tolga Öncü, said at the time. "More than ever before, we want to increase the density of our presence in the U.S., ramp up our fulfillment capacities and make our offer even more relevant to local customers' needs and dreams," he added. As the globally recognized furniture brand makes its way across the country, it will be interesting to see how its competitors respond. In any case, the bigger the offering, the better for consumers. Related: Veteran fund manager unveils eye-popping S&P 500 forecast The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
3 hours ago
- Yahoo
Alvotech's Private Placement Completed with Delivery of SDRs and Shares to Investors
Alvotech (NASDAQ: ALVO, ALVO-SDB, the 'Company'), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement that was carried out on June 4, 2025, directed to Swedish and international institutional investors. About 40 institutional investors participated in the placement. About 60% of the demand came from institutional investors based in Sweden, Norway or the UK, and about 30% from US-based funds. Over 80% of the shares and Swedish Depositary Receipts (SDRs) allocated in the placement, were sold to investors that were not previously shareholders in Alvotech. 'I'm delighted to welcome a broad group of new shareholders that are ready to join Alvotech on its exciting journey to lead the biosimilars industry, with extensive experience and background from investing in healthcare and biotech globally. This placement will further diversify and strengthen Alvotech's shareholder base and increase free float of SDRs on Nasdaq Stockholm, as about 8,5 million SDRs are already trading on the Swedish market,' said Róbert Wessman, chairman and CEO of Alvotech. All SDRs and shares allocated have now been delivered to the counterparties, with a transfer of 7.5 million treasury shares previously held by Alvotech's subsidiary Alvotech Manco ehf. Important information The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions by law. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with applicable rules in each jurisdiction. This press release is for information purposes only and does not constitute an offer to sell or an offer, or the solicitation of an offer, to acquire or subscribe for SDRs, shares or other securities issued by the Company, neither by the Company or anyone else, in any jurisdiction where such offer or invitation would be illegal prior to registration, exemption from registration or qualification under the securities laws of such jurisdiction. This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129 (the 'Prospectus Regulation') and has not been approved by any regulatory authority in any jurisdiction. The Company has not authorized any offer to the public of SDRs, shares or other securities in any member state of the EEA and no prospectus has been or will be prepared in connection with the Placement. In any EEA Member State, this communication is only addressed to and is only directed at 'qualified investors' in that Member State within the meaning of the Prospectus Regulation. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. The SDRs, the ordinary shares underlying the SDRs and the new ordinary shares referred to herein may not be sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933, as amended (the 'Securities Act'), or under the securities laws of any state or other jurisdiction of the United States and, accordingly, may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable state securities law. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. The sale of the securities referred to herein in the United States is being made solely to a limited number of 'qualified institutional buyers' as defined in Rule 144A in reliance on an exemption from the registration requirements of the Securities Act. The information in this press release may not be announced, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, within or into Australia, Belarus, Canada, Hong Kong, Japan, New Zeeland, Russia, Switzerland, Singapore, South Africa, South Korea, or in any other jurisdiction where such announcement, publication or distribution of the information would not comply with applicable laws and regulations or where such actions are subject to legal restrictions or would require additional registration or other measures than what is required under Swedish law. Actions taken in violation of this instruction may constitute a crime against applicable securities laws and regulations. In the United Kingdom, this press release and any other materials in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, 'qualified investors' who are (i) persons having professional experience in matters relating to investments who fall within the definition of 'investment professionals' in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the 'Order'); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as 'relevant persons'). In the United Kingdom, any investment or investment activity to which this communication relates is available only to, and will be engaged in only with, relevant persons. Persons who are not relevant persons should not take any action on the basis of this press release and should not act or rely on it. This announcement does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the new shares. Any investment decision to acquire or subscribe for shares in connection with the Placement must be made on the basis of all publicly available information relating to the Company and the Company's shares. Such information has not been independently verified by the Joint Bookrunners. The Joint Bookrunners are acting for the Company and no one else in connection with the Placement and are not responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the Placement or any other matter referred to herein. This press release does not constitute a recommendation for any investors' decisions regarding the Placement. Each investor or potential investor should conduct a self-examination, analysis and evaluation of the business and information described in this press release and any publicly available information. The price and value of the securities can decrease as well as increase. Achieved results do not provide guidance for future results. Neither the contents of the Company's website nor any other website accessible through hyperlinks on the Company's website are incorporated into or form part of this press release. Failure to follow these instructions may result in a breach of the Securities Act or applicable laws in other jurisdictions. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products, and services, enabled by a fully integrated approach and broad in-house capabilities. Two biosimilars, to Humira® (adalimumab) and Stelara® (ustekinumab) are already approved and marketed in multiple global markets. The current development pipeline includes nine disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. Alvotech's commercial partners include Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd. (US), STADA Arzneimittel AG (EU), Fuji Pharma Co., Ltd (Japan), Advanz Pharma (EEA, UK, Switzerland, Canada, Australia and New Zealand), Dr. Reddy's (EEA, UK and US), Biogaran (FR), Cipla/Cipla Gulf/Cipla Med Pro (Australia, New Zealand, South Africa/Africa), JAMP Pharma Corporation (Canada), Yangtze River Pharmaceutical (Group) Co., Ltd. (China), DKSH (Taiwan, Hong Kong, Cambodia, Malaysia, Singapore, Indonesia, India, Bangladesh and Pakistan), YAS Holding LLC (Middle East and North Africa), Abdi Ibrahim (Turkey), Kamada Ltd. (Israel), Mega Labs, Stein, Libbs, Tuteur and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines, and South Korea). Each commercial partnership covers a unique set of product(s) and territories. Except as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners. For more information, please visit None of the information on the Alvotech website shall be deemed part of this press release. For more information, please visit our investor portal, and our website or follow us on social media on LinkedIn, Facebook, Instagram, and YouTube. Alvotech Forward Looking StatementsCertain statements in this communication may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements generally relate to future events or the future financial operating performance of Alvotech and may include, for example, Alvotech's expectations regarding competitive advantages, business prospects and opportunities including pipeline product development, future plans and intentions, results, level of activities, performance, goals or achievements or other future events, regulatory submissions, review and interactions, the potential approval and commercial launch of its product candidates, the timing of regulatory approval, and market launches. In some cases, you can identify forward-looking statements by terminology such as 'may', 'should', 'expect', 'intend', 'will', 'estimate', 'anticipate', 'believe', 'predict', 'potential', 'aim' or 'continue', or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Alvotech and its management, are inherently uncertain and are inherently subject to risks, variability, and contingencies, many of which are beyond Alvotech's control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the ability to raise substantial additional funding, which may not be available on acceptable terms or at all; (2) the ability to maintain stock exchange listing standards; (3) changes in applicable laws or regulations; (4) the possibility that Alvotech may be adversely affected by other economic, business, and/or competitive factors; (5) Alvotech's estimates of expenses and profitability; (6) Alvotech's ability to develop, manufacture and commercialize the products and product candidates in its pipeline; (7) actions of regulatory authorities, which may affect the initiation, timing and progress of clinical studies or future regulatory approvals or marketing authorizations; (8) the ability of Alvotech or its partners to respond to inspection findings and resolve deficiencies to the satisfaction of the regulators; (9) the ability of Alvotech or its partners to enroll and retain patients in clinical studies; (10) the ability of Alvotech or its partners to gain approval from regulators for planned clinical studies, study plans or sites; (11) the ability of Alvotech's partners to conduct, supervise and monitor existing and potential future clinical studies, which may impact development timelines and plans; (12) Alvotech's ability to obtain and maintain regulatory approval or authorizations of its products, including the timing or likelihood of expansion into additional markets or geographies; (13) the success of Alvotech's current and future collaborations, joint ventures, partnerships or licensing arrangements; (14) Alvotech's ability, and that of its commercial partners, to execute their commercialization strategy for approved products; (15) Alvotech's ability to manufacture sufficient commercial supply of its approved products; (16) the outcome of ongoing and future litigation regarding Alvotech's products and product candidates; (17) the impact of worsening macroeconomic conditions, including rising inflation and interest rates and general market conditions, conflicts in Ukraine, the Middle East and other global geopolitical tension, on the Company's business, financial position, strategy and anticipated milestones; and (18) other risks and uncertainties set forth in the sections entitled 'Risk Factors' and 'Cautionary Note Regarding Forward-Looking Statements' in documents that Alvotech may from time to time file or furnish with the SEC. There may be additional risks that Alvotech does not presently know or that Alvotech currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred to in this communication. Alvotech disclaims any and all liability for any loss or damage (whether foreseeable or not) suffered or incurred by any person or entity as a result of anything contained or omitted from this communication and such liability is expressly disclaimed. The recipient agrees that it shall not seek to sue or otherwise hold Alvotech or any of its directors, officers, employees, affiliates, agents, advisors, or representatives liable in any respect for the provision of this communication, the information contained in this communication, or the omission of any information from this communication. ALVOTECH INVESTOR RELATIONS AND GLOBAL COMMUNICATIONSBenedikt Stefansson, in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
IKEA opens new format stores in Southern California and Bay Area
Swedish company IKEA is on target to open six more locations in the U.S., on top of five already opened this year, including four in California. As told by a company spokesperson to USA TODAY, the furniture retailer has plans to open three locations in Texas, and one each in Maryland, Oregon, and New Jersey. The four IKEA locations in California opened earlier this spring, most recently in Thousand Oaks, where a smaller 2,500-square-foot showroom at 60 N. Moorpark Road enables customers to get support from IKEA experts and access the full range of IKEA services, including free next-day pick-up for online orders. Called an IKEA Plan & order point with Pick-up, according to a news release from IKEA, the pick-up point offers a "blend of online and offline shopping." The IKEA Plan & order point with Pick-up is a new-format store that is part of the growth strategy for IKEA U.S.—it "increases accessibility to the brand and ensures there are more ways to meet customers where they are and how they like to shop," according to a press release. It is also different from the traditional large-format IKEA stores, as it allows customers to meet with the IKEA store team to plan and order home furnishing solutions that require a bit more help, such as kitchen, bathroom, and closet storage systems." In addition to the one at Thousand Oaks, two other IKEA Plan & order point with Pick-up California locations opened at: IKEA Ontario Plan and Order Point with Pick-up, 4150 E 4th St., Ontario IKEA Colma Plan and Order Point with Pick-up, 35 Colma Blvd, Colma In Santa Monica, IKEA opened a Pick-up point location at 3017 Wilshire Blvd. The Santa Monica Pick-up point allows customers to place any order in store or on and pick it up for free the next day, according to a press release. The location also offers the full range of IKEA services with the support of home furnishing experts, including delivery, assembly, and financing. The three new customer meeting points will bring the total number of IKEA locations to nine in the Los Angeles metro area. This expansion in the Los Angeles market is a part of the $2.2+ billion investment in the company's omnichannel growth strategy in the United States. At the end of the 2024 fiscal year, the company reported having 51 stores and 10 Plan and Order points nationwide, with 39 total pick-up locations. California has 10 IKEA retail locations, six pick-up points, and four Plan and Order Points with Pick-up. This article originally appeared on Palm Springs Desert Sun: IKEA opens new format stores Southern California, Colma.
